CN105381266A - Anti-inflammation traditional Chinese medicine - Google Patents
Anti-inflammation traditional Chinese medicine Download PDFInfo
- Publication number
- CN105381266A CN105381266A CN201510630773.2A CN201510630773A CN105381266A CN 105381266 A CN105381266 A CN 105381266A CN 201510630773 A CN201510630773 A CN 201510630773A CN 105381266 A CN105381266 A CN 105381266A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- chinese medicine
- traditional chinese
- radix
- folium eriobotryae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an anti-inflammation traditional Chinese medicine. The anti-inflammation traditional Chinese medicine is prepared from, by weight, 6-8 g of blackberrykiky rhizomes, 5-9 g of rhizoma gastrodiae, 2-6 g of rhizoma coptidis, 8-9 g of earthworms, 6-8 g of betel nut slices, 2-5 g of calculus bovis, 3-8 g of Sichuan lovage rhizomes, 3-7 g of cortex cinnamomi, 5-8 g of rhizoma typhonii, 2-6 g of forsythia suspensa, 3-8 g of radix tinosporae, 2-5 g of pseudo-ginseng, 3-6 g of radix angelica sinensis, 2-6 g of crocus sativus, 3-8 g of rhizoma paridis, 5-7 g of mentha haplocalyx Briq and 0-30 g of roasted folium eriobotryae. The anti-inflammation traditional Chinese medicine is significant in treatment effect and has the advantages of being low in cost, cheap, easy to popularize and the like.
Description
Technical field
The present invention relates to a kind of Chinese medicine, especially a kind of Chinese medicine of antiinflammatory.
Background technology
Inflammation is often referred to " inflammation ", be biological tissue be subject to certain stimulate as wound, the infection equivalent damage factor stimulation a kind of basic pathology process based on defense reaction of occurring.The topical manifestations of inflammation is red, swollen, hot, pain and dysfunction, also with general reactions such as heating, the changes of peripheral blood numeration of leukocyte.
In view of the defect existed in above prior art, be necessary it to improve further, make it have more standby practicality, could realistic service condition.
Summary of the invention
In order to overcome the defect of above-mentioned prior art, the object of this invention is to provide a kind of stomach health care Chinese medicine.
The present invention takes following technical scheme to realize: a kind of Chinese medicine of antiinflammatory, is made up of the raw material of Chinese medicine of following weight proportion: Rhizoma Belamcandae 6-8g, Rhizoma Gastrodiae 5-9g, Rhizoma Coptidis 2-6g, Pheretima 8-9g, bulky 6-8g, Calculus Bovis 2-5g, Rhizoma Chuanxiong 3-8g, Cortex Cinnamomi 3-7g, Rhizoma Typhonii 5-8g, Fructus Forsythiae 2-6g, Radix Tinosporae 3-8g, Radix Notoginseng 2-5g, Radix Angelicae Sinensis 3-6g, Stigma Croci 2-6g, Rhizoma Paridis 3-8g, HERBA MENTHAE 5-7g, Folium Eriobotryae (processed) 0-30g.
Particularly, Rhizoma Belamcandae 8g of the present invention, Rhizoma Gastrodiae 7g, Rhizoma Coptidis 4g, Pheretima 6g, bulky 7g, Calculus Bovis 3g, Rhizoma Chuanxiong 7g, Cortex Cinnamomi 5g, Rhizoma Typhonii 7g, Fructus Forsythiae 5g, Radix Tinosporae 5g, Radix Notoginseng 3g, Radix Angelicae Sinensis 4g, Stigma Croci 5g, Rhizoma Paridis 6g, HERBA MENTHAE 5g, Folium Eriobotryae (processed) 20-25g.
Particularly, Folium Eriobotryae (processed) 23g of the present invention.
Beneficial effect of the present invention: the present invention accepts clinic case more than 98 people for medical treatment, and total effective rate reaches 95%, the present invention is the significant anti-inflammatory medicine of a kind of therapeutic effect, has that cost is low, a low price, easily universal isopreference.Wherein Rhizoma Paridis has heat-clearing and toxic substances removing, reducing swelling and alleviating pain, effect of cool liver arresting convulsion.
Detailed description of the invention
For make the present invention existing technological means, creation characteristic, reach object and effect is easy to understand, below in conjunction with detailed description of the invention, set forth the present invention further.
The present invention takes following technical scheme to realize: a kind of Chinese medicine of antiinflammatory, and it is made up of the raw material of Chinese medicine of following weight proportion: Rhizoma Belamcandae 6-8g, Rhizoma Gastrodiae 5-9g, Rhizoma Coptidis 2-6g, Pheretima 8-9g, bulky 6-8g, Calculus Bovis 2-5g, Rhizoma Chuanxiong 3-8g, Cortex Cinnamomi 3-7g, Rhizoma Typhonii 5-8g, Fructus Forsythiae 2-6g, Radix Tinosporae 3-8g, Radix Notoginseng 2-5g, Radix Angelicae Sinensis 3-6g, Stigma Croci 2-6g, Rhizoma Paridis 3-8g, HERBA MENTHAE 5-7g, Folium Eriobotryae (processed) 0-30g.
As preferred version of the present invention, Rhizoma Belamcandae 8g of the present invention, Rhizoma Gastrodiae 7g, Rhizoma Coptidis 4g, Pheretima 6g, bulky 7g, Calculus Bovis 3g, Rhizoma Chuanxiong 7g, Cortex Cinnamomi 5g, Rhizoma Typhonii 7g, Fructus Forsythiae 5g, Radix Tinosporae 5g, Radix Notoginseng 3g, Radix Angelicae Sinensis 4g, Stigma Croci 5g, Rhizoma Paridis 6g, HERBA MENTHAE 5g, Folium Eriobotryae (processed) 20-25g.
As preferred version of the present invention, Folium Eriobotryae (processed) 23g of the present invention.
Usage and consumption: take 1 note day, decocting removes slag, and to obtain final product, divide and take for 2 to 3 times.Within one week, be a course for the treatment of, generally take 1-3 the course for the treatment of.
Although give detailed description and explanation to the specific embodiment of the present invention above; but what should indicate is; we can carry out various equivalence according to conception of the present invention to above-mentioned embodiment and change and amendment; its function produced do not exceed that description contains yet spiritual time, all should within protection scope of the present invention.
Claims (3)
1. the Chinese medicine of an antiinflammatory; it is characterized in that, it is made up of the raw material of Chinese medicine of following weight proportion: Rhizoma Belamcandae 6-8g, Rhizoma Gastrodiae 5-9g, Rhizoma Coptidis 2-6g, Pheretima 8-9g, bulky 6-8g, Calculus Bovis 2-5g, Rhizoma Chuanxiong 3-8g, Cortex Cinnamomi 3-7g, Rhizoma Typhonii 5-8g, Fructus Forsythiae 2-6g, Radix Tinosporae 3-8g, Radix Notoginseng 2-5g, Radix Angelicae Sinensis 3-6g, Stigma Croci 2-6g, Rhizoma Paridis 3-8g, HERBA MENTHAE 5-7g, Folium Eriobotryae (processed) 0-30g.
2. the Chinese medicine of antiinflammatory according to claim 1, is characterized in that: it is made up of the crude drug of following weight portion: Rhizoma Belamcandae 8g, Rhizoma Gastrodiae 7g, Rhizoma Coptidis 4g, Pheretima 6g, bulky 7g, Calculus Bovis 3g, Rhizoma Chuanxiong 7g, Cortex Cinnamomi 5g, Rhizoma Typhonii 7g, Fructus Forsythiae 5g, Radix Tinosporae 5g, Radix Notoginseng 3g, Radix Angelicae Sinensis 4g, Stigma Croci 5g, Rhizoma Paridis 6g, HERBA MENTHAE 5g, Folium Eriobotryae (processed) 20-25g.
3. the Chinese medicine of antiinflammatory according to claim 1, is characterized in that: it is made up of the crude drug of following weight portion: Folium Eriobotryae (processed) 23g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510630773.2A CN105381266A (en) | 2015-09-29 | 2015-09-29 | Anti-inflammation traditional Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510630773.2A CN105381266A (en) | 2015-09-29 | 2015-09-29 | Anti-inflammation traditional Chinese medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105381266A true CN105381266A (en) | 2016-03-09 |
Family
ID=55414442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510630773.2A Withdrawn CN105381266A (en) | 2015-09-29 | 2015-09-29 | Anti-inflammation traditional Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105381266A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103285248B (en) * | 2013-06-05 | 2015-03-18 | 冯欢庆 | Antiphlogistic traditional Chinese medicine |
| CN104800612A (en) * | 2015-05-25 | 2015-07-29 | 合肥丰瑞隆生物科技有限公司 | Anti-inflammatory traditional Chinese medicine |
| CN104887986A (en) * | 2015-06-17 | 2015-09-09 | 安徽医联大成医药科技有限公司 | Traditional Chinese medicine capable of diminishing inflammations |
-
2015
- 2015-09-29 CN CN201510630773.2A patent/CN105381266A/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103285248B (en) * | 2013-06-05 | 2015-03-18 | 冯欢庆 | Antiphlogistic traditional Chinese medicine |
| CN104800612A (en) * | 2015-05-25 | 2015-07-29 | 合肥丰瑞隆生物科技有限公司 | Anti-inflammatory traditional Chinese medicine |
| CN104887986A (en) * | 2015-06-17 | 2015-09-09 | 安徽医联大成医药科技有限公司 | Traditional Chinese medicine capable of diminishing inflammations |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104800612A (en) | Anti-inflammatory traditional Chinese medicine | |
| CN103751497A (en) | Medicament for treating mastitis and preparation method thereof | |
| CN104042543A (en) | Anti-acne mask and making method thereof | |
| CN104147502A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of traditional Chinese medicine composition | |
| CN103223089A (en) | Viper antidote | |
| CN104887986A (en) | Traditional Chinese medicine capable of diminishing inflammations | |
| CN105381266A (en) | Anti-inflammation traditional Chinese medicine | |
| CN104027514A (en) | Traditional Chinese medicine used for treating acute cholecystitis | |
| CN103463570B (en) | Pharmaceutical composition and preparation method, preparation and application thereof | |
| CN105396025A (en) | Traditional Chinese medicine analgesic paste for relieving cancer pain and effective ingredients and preparation method thereof | |
| CN1899512A (en) | Chinese herbal medicine paste for treating hard atrophic type dystrophy of vulva | |
| CN103566097A (en) | Traditional Chinese medicine composition for treating tetanus | |
| CN103550460A (en) | Traditional Chinese medicine formula for treatment of dysmenorrhoea | |
| CN103041192A (en) | Bedsore paste | |
| CN103055051B (en) | Liquid for treating burn and scald | |
| CN102885943A (en) | External Chinese medicinal liniment for treating psoriasis | |
| CN101584839A (en) | Chinese medicament for treating acute and chronic cholecystitis | |
| CN105343803A (en) | Traditional Chinese medicine ointment for treating gynecological inflammation | |
| CN104001031A (en) | Medicament for treating asthma | |
| CN104173779A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
| CN107320648A (en) | A kind of Chinese medicine of anti-inflammatory | |
| CN107198748A (en) | A kind of Chinese medicine of anti-inflammatory | |
| CN104208525A (en) | Traditional Chinese medicine composition for treating skin cancer | |
| CN102961634A (en) | External Chinese medicinal preparation for treating psoriasis and preparation method thereof | |
| CN110876792A (en) | Borneol plaster for relaxing muscles and tendons and activating collaterals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160309 |